ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Kiladjian, Jean-Jacques; García-Gutierrez, Valentin; Nicolini, Franck-Emmanuel; Guglielmelli, Paola; Danaila, Catalin Doru; Koschmieder, Steffen; Palandri, Francesca; Crisan, Ana-Manuela; James, Chloe; Pappa, Vassiliki; Empson, Victoria; Alvarez-Larrán, Alberto; Breccia, Massimo; Krejcy, Kurt; Tomuleasa, Ciprian; De Stefano, Valerio; Cerna, Olga; Klade, Christoph; Heidel, Florian H.; Cirici, Blanca Xicoy; Gora-Tybor, Joanna; Grosicki, Sebastian; Bieniaszewska, Maria; Wölfler, Albert; Al-Ali, Haifa Kathrin; Sacha, Tomasz; Lazaroiu, Mihaela-Cornelia; Terpos, Evangelos; Illés, Arpád; Griesshammer, Martin; Mayer, Jiri; Reiter, Andreas Johannes; Beggiato, Eloise; Schmidt, Stefan; Unger, Martin; Marin, Francisca Ferrer; Döhner, Konstanze; Schlager, Stefanie; Buxhofer-Ausch, Veronika; Nagy, Zsolt György; Krauth, Maria-Theresa

doi:SCOPUS:2-s2.0-85186554819

Mehr Informationen
Referenzen (0)
Diskussion (0)
Dateien

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options - RWTH-CONV-254446

Ähnliche Datensätze

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines